THALIDOMIDE Side Effects

7019978-5 | Cardiac Disorder, Nervous System Disorder, Thrombosis
on Dec 13, 2007 Female patient from FRANCE , 87 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac disorder, nervous system disorder, thrombosis. Thalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BISPHOSPHONATES (View Bisphosphonates Review and Bisphosphonates Label ).

7017958-7 | Azotaemia, Cardiac Arrest, Hyperammonaemic Encephalopathy
Patient was taking Thalidomide (View Usage). Patient had the following side effects: azotaemia, cardiac arrest (What is cardiac arrest?), hyperammonaemic encephalopathy on Sep 21, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 86 years of age, was diagnosed with hyperammonaemic encephalopathy and. Thalidomide dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), L ORNITHINE L ASPARTATE (View L-ornithine-l-aspartate Review and L-ornithine-l-aspartate Label ), L ORNITHINE L ASPARTATE (View L-ornithine-l-aspartate Review and L-ornithine-l-aspartate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

7015301-0 | Plasmacytoma
Adverse event was reported on Sep 22, 2010 by a Male patient taking Thalidomide (View Usage) (Dosage: ) was diagnosed with plasmacytoma and. Location: GERMANY , 74 years of age, weighting 196.2 lb, After Thalidomide was administered, patient had the following side effects: plasmacytoma. During the same period patient was treated with METAMIZOLE (View Metamizole Review and Metamizole Label ), RAMIPRIL/HYDROCHLOORTHIAZIDE (View Ramipril/hydrochloorthiazide Review and Ramipril/hydrochloorthiazide Label ).

7014807-8 | Confusional State, Disease Progression, Leukaemia Plasmacytic, Neoplasm
on Sep 24, 2010 Female patient from FRANCE , weighting 132.3 lb, was treated with Thalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, disease progression, leukaemia plasmacytic, neoplasm. Thalidomide dosage: . Patient was hospitalized.


7014757-7 | Visceral Leishmaniasis
on Sep 14, 2010 Female patient from ITALY , 64 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalidomide (View Usage). Patient had the following side effects: visceral leishmaniasis. Thalidomide dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), STEROIDS (View Steroids Review and Steroids Label ).

7014492-5 | Enterobacter Sepsis
Patient was taking Thalidomide (View Usage). After Thalidomide was administered, patient had the following side effects: enterobacter sepsis on Sep 22, 2010 from AUSTRALIA Additional patient health information: Male patient , weighting 176.4 lb, . Thalidomide dosage: . During the same period patient was treated with AZACITIDINE (View Azacitidine Review and Azacitidine Label ). Patient was hospitalized.

7014343-9 | Visceral Leishmaniasis
Adverse event was reported on Sep 14, 2010 by a Male patient taking Thalidomide (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: ITALY , 43 years of age, Patient experienced the following unwanted or unexpected effects: visceral leishmaniasis. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), STEROIDS (View Steroids Review and Steroids Label ), ENDOXAN (View Endoxan Review and Endoxan Label ).

7010659-0 | Supraventricular Tachycardia
on Sep 14, 2010 Female patient from CANADA , weighting 134.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalidomide (View Usage). Patient had the following side effects: supraventricular tachycardia. Thalidomide dosage: . During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATACAND (View Atacand Review and Atacand Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

7009336-1 | Pregnancy Of Partner
on Sep 08, 2010 Male patient from BELGIUM , 22 years of age, was treated with Thalidomide (View Usage). After Thalidomide was administered, patient had the following side effects: pregnancy of partner. Thalidomide dosage: .

7007330-8 | Sciatica
Patient was taking Thalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: sciatica (What is sciatica?) on Sep 09, 2010 from FRANCE Additional patient health information: Female patient , weighting 147.7 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), constipation (What is constipation?), prophylaxis, thrombosis prophylaxis and. Thalidomide dosage: . During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), TRANSIPEG (2 Bags) (View Transipeg Review and Transipeg Label ), EFFERALGAN (View Efferalgan Review and Efferalgan Label ), NOCTAMIDE (View Noctamide Review and Noctamide Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

7005046-5 | Dyspnoea, Pneumonia, Sepsis, Shock
Adverse event was reported on Sep 16, 2010 by a Female patient taking Thalidomide (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), prophylaxis, hypertension, decreased appetite and. Location: KOREA, REPUBLIC OF , weighting 108.5 lb, Patient had the following side effects: dyspnoea, pneumonia (What is pneumonia?), sepsis (What is sepsis?), shock. During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PRIGEL (View Prigel Review and Prigel Label ), BEECOM (View Beecom Review and Beecom Label ), NORVASC (View Norvasc Review and Norvasc Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), POTASSIUM CHLORIDE (20 Meq) (View Potassium Chloride Review and Potassium Chloride Label ), APETROL (View Apetrol Review and Apetrol Label ).

7005000-3 | Oropharyngeal Candidiasis, Vomiting, Weight Decreased
on Sep 08, 2010 Male patient from FRANCE , weighting 114.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), thrombosis prophylaxis and was treated with Thalidomide (View Usage). After Thalidomide was administered, patient had the following side effects: oropharyngeal candidiasis, vomiting, weight decreased. Thalidomide dosage: . During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ASPERGIC (View Aspergic Review and Aspergic Label ). Patient was hospitalized.

6994301-0 | Malaise, Pyrexia, Sleep Apnoea Syndrome
on Sep 07, 2010 Male patient from BELGIUM , weighting 173.7 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), constipation (What is constipation?) and was treated with Thalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: malaise, pyrexia, sleep apnoea syndrome. Thalidomide dosage: . During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NULYTELY (View Nulytely Review and Nulytely Label ). Patient was hospitalized.

6987594-7 | Pulmonary Embolism, Thrombosis
Patient was taking Thalidomide (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?), thrombosis on May 19, 2009 from AUSTRALIA Additional patient health information: Female patient , weighting 160.2 lb, was diagnosed with myelodysplastic syndrome, thrombosis prophylaxis, pulmonary embolism (What is pulmonary embolism?) and. Thalidomide dosage: . During the same period patient was treated with VIDAZA (View Vidaza Review and Vidaza Label ), CLEXANE (View Clexane Review and Clexane Label ). Patient was hospitalized.

6985906-1 | Interstitial Lung Disease, Pyrexia
Adverse event was reported on Sep 03, 2010 by a Male patient taking Thalidomide (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: NETHERLANDS , weighting 192.7 lb, After Thalidomide was administered, patient had the following side effects: interstitial lung disease, pyrexia. During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6985239-3 | Dyspnoea, Pneumonia, Sepsis, Shock
on Sep 10, 2010 Female patient from KOREA, REPUBLIC OF , weighting 108.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), prophylaxis, hypertension, decreased appetite and was treated with Thalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, pneumonia (What is pneumonia?), sepsis (What is sepsis?), shock. Thalidomide dosage: . During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PRIGEL (View Prigel Review and Prigel Label ), BEECOM (View Beecom Review and Beecom Label ), NORVASC (View Norvasc Review and Norvasc Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), POTASSIUM CHLORIDE (20 Meq) (View Potassium Chloride Review and Potassium Chloride Label ), APETROL (View Apetrol Review and Apetrol Label ).

6979020-9 | Septic Shock
on Sep 06, 2010 Male patient from ITALY , weighting 194.0 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalidomide (View Usage). Patient had the following side effects: septic shock. Thalidomide dosage: 100 Mgx15 Days Then 200mg Up To 42 Days. During the same period patient was treated with DELTACORTONE (View Deltacortone Review and Deltacortone Label ), ALKERAN (View Alkeran Review and Alkeran Label ), VFEND (View Vfend Review and Vfend Label ). Patient was hospitalized.

6978432-7 | Aortic Stenosis, Hepatic Cirrhosis
Patient was taking Thalidomide (View Usage). After Thalidomide was administered, patient had the following side effects: aortic stenosis, hepatic cirrhosis on Sep 03, 2010 from NEW ZEALAND Additional patient health information: Female patient , weighting 143.3 lb, . Thalidomide dosage: .

6977308-9 | Cardio-respiratory Arrest, Pneumonia, Pulmonary Congestion, Sepsis
Adverse event was reported on Sep 06, 2010 by a Male patient taking Thalidomide (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: LEBANON , 69 years of age, Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, pneumonia (What is pneumonia?), pulmonary congestion, sepsis (What is sepsis?). During the same period patient was treated with AMOL (View Amol Review and Amol Label ), BREANSIM (View Breansim Review and Breansim Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), CALCIUM (View Calcium Review and Calcium Label ), EVRO D (View Evro D Review and Evro D Label ). Patient was hospitalized.

6973165-5 | Constipation, Decreased Appetite, Dehydration, Peripheral Motor Neuropathy
on Aug 30, 2010 Male patient from SWITZERLAND , weighting 151.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), bone pain, prophylaxis and was treated with Thalidomide (View Usage). Patient had the following side effects: constipation (What is constipation?), decreased appetite, dehydration, peripheral motor neuropathy. Thalidomide dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), MORPHINE (View Morphine Review and Morphine Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6968185-0 | Bone Marrow Failure, Infection, Venous Thrombosis
on Aug 24, 2010 Female patient from FINLAND , 83 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalidomide (View Usage). After Thalidomide was administered, patient had the following side effects: bone marrow failure, infection (What is infection?), venous thrombosis. Thalidomide dosage: .

6967739-5 | Cataract
Patient was taking Thalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?) on Aug 24, 2010 from FRANCE Additional patient health information: Male patient , weighting 189.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), gastrooesophageal reflux prophylaxis and. Thalidomide dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), COKENZEN (View Cokenzen Review and Cokenzen Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6967627-4 | Heart Transplant Rejection
Adverse event was reported on Aug 24, 2010 by a Female patient taking Thalidomide (View Usage) (Dosage: ) . Location: BELGIUM , 66 years of age, Patient had the following side effects: heart transplant rejection. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ).

6962457-1 | Interstitial Lung Disease, Pyrexia
on Aug 23, 2010 Male patient from NETHERLANDS , weighting 192.7 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalidomide (View Usage). After Thalidomide was administered, patient had the following side effects: interstitial lung disease, pyrexia. Thalidomide dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6962125-6 | Bone Marrow Toxicity
on Aug 18, 2010 Male patient from DENMARK , 78 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow toxicity. Thalidomide dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6960358-6 | Bone Marrow Toxicity
Patient was taking Thalidomide (View Usage). Patient had the following side effects: bone marrow toxicity on Aug 19, 2010 from SWEDEN Additional patient health information: Female patient , 70 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Thalidomide dosage: .

6960201-5 | Spinal Fracture
Adverse event was reported on Aug 19, 2010 by a Female patient taking Thalidomide (View Usage) (Dosage: ) . Location: GERMANY , 68 years of age, weighting 110.2 lb, After Thalidomide was administered, patient had the following side effects: spinal fracture. Patient was hospitalized.

6956815-9 | Decubitus Ulcer
on Aug 18, 2010 Female patient from FRANCE , weighting 123.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), thrombosis prophylaxis and was treated with Thalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: decubitus ulcer. Thalidomide dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6955220-9 | Acquired Epidermolysis Bullosa
on Aug 18, 2010 Male patient from FRANCE , weighting 149.9 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), infection prophylaxis and was treated with Thalidomide (View Usage). Patient had the following side effects: acquired epidermolysis bullosa. Thalidomide dosage: . During the same period patient was treated with MYOLASTAN (View Myolastan Review and Myolastan Label ), BACTRIM (View Bactrim Review and Bactrim Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), VELCADE (View Velcade Review and Velcade Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), ORACILLIN (View Oracillin Review and Oracillin Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

6940168-6 | Bone Lesion, Dyspnoea, Fatigue, Leukaemia Plasmacytic, Pleural Effusion, Pneumothorax, Productive Cough, Pulmonary Congestion, Somnolence
Patient was taking Thalidomide (View Usage). After Thalidomide was administered, patient had the following side effects: bone lesion, dyspnoea, fatigue, leukaemia plasmacytic, pleural effusion, pneumothorax, productive cough, pulmonary congestion, somnolence on Aug 11, 2010 from PAKISTAN Additional patient health information: Female patient , 55 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Thalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6931288-0 | Acute Monocytic Leukaemia, Respiratory Failure
Adverse event was reported on Aug 04, 2010 by a Male patient taking Thalidomide (View Usage) (Dosage: 200 Mg, Oral, 100 Meq, Oral) was diagnosed with histiocytosis and. Location: PORTUGAL , 62 years of age, Patient experienced the following unwanted or unexpected effects: acute monocytic leukaemia, respiratory failure.

6930293-8 | Cerebral Artery Stenosis, Transient Ischaemic Attack
on Aug 05, 2010 Female patient from GERMANY , 49 years of age, weighting 191.4 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), tonsillitis and was treated with Thalidomide (View Usage). Patient had the following side effects: cerebral artery stenosis, transient ischaemic attack. Thalidomide dosage: . During the same period patient was treated with CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), CALCIUM/VITAMIN D (View Calcium/vitamin D Review and Calcium/vitamin D Label ). Patient was hospitalized.

6928513-9 | Arterial Occlusive Disease, Arteritis, Carotid Artery Stenosis, Hemiparesis
on Aug 12, 2010 Female patient from GERMANY , child 4. years of age, was diagnosed with meningitis tuberculous and was treated with Thalidomide (View Usage). After Thalidomide was administered, patient had the following side effects: arterial occlusive disease, arteritis, carotid artery stenosis, hemiparesis. Thalidomide dosage: 25-50 Mg. During the same period patient was treated with PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), RIFAMPIN (View Rifampin Review and Rifampin Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized and became disabled.

6928331-1 | Decubitus Ulcer
Patient was taking Thalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: decubitus ulcer on Aug 09, 2010 from FRANCE Additional patient health information: Female patient , weighting 123.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), thrombosis prophylaxis and. Thalidomide dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6927483-7 | Constipation, Decreased Appetite, Dehydration, Neuropathy Peripheral
Adverse event was reported on Aug 05, 2010 by a Male patient taking Thalidomide (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), bone pain, prophylaxis and. Location: SWITZERLAND , weighting 151.5 lb, Patient had the following side effects: constipation (What is constipation?), decreased appetite, dehydration, neuropathy peripheral. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), MORPHINE (View Morphine Review and Morphine Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6925380-4 | Epidermolysis Bullosa
on Aug 05, 2010 Male patient from FRANCE , weighting 149.9 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), infection prophylaxis and was treated with Thalidomide (View Usage). After Thalidomide was administered, patient had the following side effects: epidermolysis bullosa. Thalidomide dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), ORACILLIN (View Oracillin Review and Oracillin Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), ZOMETA (View Zometa Review and Zometa Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ). Patient was hospitalized.

6924183-4 | Asthenia, Dyspnoea, Fatigue, Hyperhidrosis, Lung Abscess, Lung Infiltration, Pulmonary Mass, Pulmonary Necrosis, Respiratory Tract Inflammation
on Aug 12, 2010 Male patient from UNITED STATES , weighting 202.2 lb, was diagnosed with myelofibrosis and was treated with Thalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dyspnoea, fatigue, hyperhidrosis, lung abscess, lung infiltration, pulmonary mass, pulmonary necrosis, respiratory tract inflammation. Thalidomide dosage: 50mg Every 48 Hours Po. During the same period patient was treated with DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ), SENNA (View Senna Review and Senna Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), METOPROLOL SUCCINATE EXTENDED RELEASE (View Metoprolol Succinate Extended Release Review and Metoprolol Succinate Extended Release Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), BUPROPION HCL (View Bupropion Hcl Review and Bupropion Hcl Label ), TUMS (View Tums Review and Tums Label ). Patient was hospitalized.

6919507-8 | Presyncope
Patient was taking Thalidomide (View Usage). Patient had the following side effects: presyncope on Aug 02, 2010 from ITALY Additional patient health information: Male patient , weighting 201.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), prophylaxis and. Thalidomide dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), MODURETIC 5 50 (View Moduretic 5-50 Review and Moduretic 5-50 Label ).

6910837-2 | Rib Fracture
Adverse event was reported on Jul 27, 2010 by a Female patient taking Thalidomide (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), hypertension, pain (What is pain?) and. Location: NETHERLANDS , weighting 127.9 lb, After Thalidomide was administered, patient had the following side effects: rib fracture. During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), ACETYLSCARDIO (View Acetylscardio Review and Acetylscardio Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MOVICOLON (View Movicolon Review and Movicolon Label ). Patient was hospitalized.

6910545-8 | Anaemia, Hypercalcaemia, Leukaemia Plasmacytic, Light Chain Analysis Increased, Renal Failure
on Jul 23, 2010 Male patient from POLAND , 71 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, hypercalcaemia, leukaemia plasmacytic, light chain analysis increased, renal failure. Thalidomide dosage: 100-300mg.

6907829-6 | Abscess, Cellulitis, Dizziness, Gastrointestinal Disorder, Osteitis
on Jul 22, 2010 Female patient from SWITZERLAND , 61 years of age, was diagnosed with type 2 lepra reaction and was treated with Thalidomide (View Usage). Patient had the following side effects: abscess (What is abscess?), cellulitis (What is cellulitis?), dizziness (What is dizziness?), gastrointestinal disorder, osteitis. Thalidomide dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ).

6906091-8 | Gastrooesophageal Reflux Disease, Hiatus Hernia, Malignant Breast Lump Removal, Periarthritis
Patient was taking Thalidomide (View Usage). After Thalidomide was administered, patient had the following side effects: gastrooesophageal reflux disease, hiatus hernia, malignant breast lump removal, periarthritis on Jul 27, 2010 from ITALY Additional patient health information: Female patient , 74 years of age, was diagnosed with gastrointestinal angiodysplasia and. Thalidomide dosage: . During the same period patient was treated with DELTACORTENE (View Deltacortene Review and Deltacortene Label ), ESOPRAL (View Esopral Review and Esopral Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), TACHIPIRINA (View Tachipirina Review and Tachipirina Label ), UNIPRIL (View Unipril Review and Unipril Label ), TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ). Patient was hospitalized.

6905378-2 | Ventricular Fibrillation
Adverse event was reported on Jul 29, 2010 by a Male patient taking Thalidomide (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), atrial fibrillation (What is atrial fibrillation?) and. Location: NETHERLANDS , weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: ventricular fibrillation. During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ALKERAN (View Alkeran Review and Alkeran Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ). Patient was hospitalized.

6900627-9 | Confusional State, Neoplasm
on Jul 27, 2010 Female patient from FRANCE , 71 years of age, was treated with Thalidomide (View Usage). Patient had the following side effects: confusional state, neoplasm. Thalidomide dosage: .

6887812-X | Lung Infection, Nervous System Disorder
on Jul 22, 2010 Male patient from TURKEY , weighting 125.7 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), nervous system disorder and was treated with Thalidomide (View Usage). After Thalidomide was administered, patient had the following side effects: lung infection, nervous system disorder. Thalidomide dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B (View Vitamin B Review and Vitamin B Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6886990-6 | Decubitus Ulcer
Patient was taking Thalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: decubitus ulcer on Jul 21, 2010 from FRANCE Additional patient health information: Female patient , weighting 123.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), thrombosis prophylaxis and. Thalidomide dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6870990-6 | Constipation, Dehydration, Delirium
Adverse event was reported on Jul 14, 2010 by a Female patient taking Thalidomide (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), hypertension, prophylaxis, pain (What is pain?) and. Location: NETHERLANDS , weighting 196.2 lb, Patient had the following side effects: constipation (What is constipation?), dehydration, delirium. During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), COTRIM (1/2 Tablet) (View Cotrim Review and Cotrim Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), ORAMORPH SR (View Oramorph Sr Review and Oramorph Sr Label ). Patient was hospitalized.

6867406-2 | Cerebral Haemorrhage, Pulmonary Embolism
on Jul 16, 2010 Male patient from GERMANY , 21 years of age, was treated with Thalidomide (View Usage). After Thalidomide was administered, patient had the following side effects: cerebral haemorrhage, pulmonary embolism (What is pulmonary embolism?). Thalidomide dosage: . During the same period patient was treated with TEMOZOLOMIDE (View Temozolomide Review and Temozolomide Label ), TOPOTECAN (View Topotecan Review and Topotecan Label ), BACTRIM (3 Cm) (View Bactrim Review and Bactrim Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), ZOFRAN (View Zofran Review and Zofran Label ).

6867017-9 | Cardio-respiratory Arrest, Pulmonary Congestion
on Jul 20, 2010 Male patient from LEBANON , 69 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, pulmonary congestion. Thalidomide dosage: . During the same period patient was treated with AMOL (View Amol Review and Amol Label ), BREANSIM (View Breansim Review and Breansim Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), CALCIUM (View Calcium Review and Calcium Label ), EVRO D (View Evro D Review and Evro D Label ).

6866512-6 | Haemorrhagic Diathesis, Multi-organ Failure, Pneumonia, Respiratory Failure
Patient was taking Thalidomide (View Usage). Patient had the following side effects: haemorrhagic diathesis, multi-organ failure, pneumonia (What is pneumonia?), respiratory failure on Jul 19, 2010 from PHILIPPINES Additional patient health information: Female patient , weighting 165.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), hypertension, diabetes mellitus and. Thalidomide dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), INSULIN (View Insulin Review and Insulin Label ).